Lemaitre Vascular Inc

Research Lemaitre Vascular Inc (LMAT) on Bullrun: valuation model: 3.5% undervalued, market cap USD 2.19B, P/E 35.4, dividend yield 0.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLMAT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Instruments & Supplies
• CurrencyUSD
• Valuation signal3.5% undervalued
• Market capUSD 2.19B
• P/E35.4
• Dividend yield0.9%
• Financial periodFY2025
• RevenueUSD 249.60M
• Revenue growth13.5%
• Net incomeUSD 57.70M
• Free cash flowUSD 74.47M
• Gross margin71.5%

Valuation Snapshot

Bullrun's latest valuation model marks Lemaitre Vascular Inc as 3.5% undervalued; latest market cap is USD 2.19B; P/E is 35.4; dividend yield is 0.9%.

About Lemaitre Vascular Inc

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system;

Frequently asked questions

Is Lemaitre Vascular Inc overvalued or undervalued?

Bullrun's valuation model currently marks Lemaitre Vascular Inc as 3.5% undervalued.

What is Lemaitre Vascular Inc's market cap?

Lemaitre Vascular Inc's market capitalization is USD 2.19B.

What is Lemaitre Vascular Inc's P/E ratio?

Lemaitre Vascular Inc's price-to-earnings (P/E) ratio is 35.4.

Does Lemaitre Vascular Inc pay a dividend?

Lemaitre Vascular Inc has a dividend yield of 0.9%.

What does Lemaitre Vascular Inc do?

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.